Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Dozens of protesters gathered outside the practice of a suburban Minneapolis dentist who killed a protected lion in Zimbabwe.
Ramsay Street, the set of long-running Australian soap Neighbours, is to be transformed into a hotel for fans.
The average Brit spends almost ten years of their lives in front of the television, research has suggested.